Single User License
INR 8058
Site License
INR 16115
Corporate User License
INR 24173

Service Tax Additional

select a format
Price

Single User License
USD 125
Site License
USD 250
Corporate User License
USD 375

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


bluebird bio Inc (BLUE)-Financial and Strategic SWOT Analysis Review

bluebird bio Inc (BLUE)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH137067FSA
  • |
  • Pages: 48
  • |
  • March 2017
  • |
  • |
  Request for Sample Report

Executive Summary

bluebird bio Inc (BLUE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company, which researches and develops new gene therapies for the treatment of serious genetic and orphan diseases. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. The company's product pipeline includes Lenti D under evaluation for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of beta thalassemia (TDT) and sickle cell anemia, besides compounds under development for the treatment of various cancers. The company has collaboration with various pharmaceutical companies to discover, develop and commercialize gene therapy products to treat cancer. bluebird bio is headquartered in Cambridge, Massachusetts, the US.

bluebird bio Inc Key Recent Developments

Feb 22, 2017: bluebird bio Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Progress

Dec 15, 2016: bluebird bio and apceth Biopharm a Establish Commercial Drug Product Manufacturing Agreement

Dec 02, 2016: bluebird bio names new COO

Dec 02, 2016: bluebird bio Announces Management Appointments

Nov 02, 2016: bluebird bio Reports Third Quarter 2016 Financial Results and Recent Operational Progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

bluebird bio Inc-Key Facts 6

bluebird bio Inc-Key Employees 7

bluebird bio Inc-Key Employee Biographies 8

bluebird bio Inc-Major Products and Services 10

bluebird bio Inc-Pharmaceutical Pipeline Products Data 11

bluebird bio Inc, Pipeline Products by Therapy Area 11

bluebird bio Inc, Pipeline Products by Development Phase 12

bluebird bio Inc-History 13

bluebird bio Inc-Company Statement 14

bluebird bio Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

bluebird bio Inc-Business Description 16

bluebird bio Inc-Corporate Strategy 17

bluebird bio Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

bluebird bio Inc-Strengths 18

bluebird bio Inc-Weaknesses 19

bluebird bio Inc-Opportunities 20

bluebird bio Inc-Threats 21

bluebird bio Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30

bluebird bio Inc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Feb 22, 2017: bluebird bio Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Progress 32

Dec 15, 2016: bluebird bio and apceth Biopharm a Establish Commercial Drug Product Manufacturing Agreement 34

Dec 02, 2016: bluebird bio names new COO 35

Dec 02, 2016: bluebird bio Announces Management Appointments 36

Nov 02, 2016: bluebird bio Reports Third Quarter 2016 Financial Results and Recent Operational Progress 37

Aug 03, 2016: bluebird bio Reports Second Quarter 2016 Financial Results and Recent Operational Progress 38

Jul 18, 2016: bluebird bio Presents megaTAL Genome Editing Data at American Society of Hematology (ASH) Workshop on Genome Editing 40

May 04, 2016: bluebird bio Reports First Quarter 2016 Financial Results and Recent Operational Progress 41

Apr 18, 2016: bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting 42

Feb 25, 2016: bluebird bio Announces Transition of Chief Financial Officer 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

bluebird bio Inc, Pipeline Products by Therapy Area 11

bluebird bio Inc, Pipeline Products by Development Phase 12

bluebird bio Inc, Performance Chart (2012-2016) 26

bluebird bio Inc, Ratio Charts 28

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 30

List of Tables

bluebird bio Inc, Key Facts 6

bluebird bio Inc, Key Employees 7

bluebird bio Inc, Key Employee Biographies 8

bluebird bio Inc, Major Products and Services 10

bluebird bio Inc, Number of Pipeline Products by Therapy Area 11

bluebird bio Inc, Number of Pipeline Products by Development Stage 12

bluebird bio Inc, History 13

bluebird bio Inc, Other Locations 15

bluebird bio Inc, Subsidiaries 15

bluebird bio Inc, Key Competitors 22

bluebird bio Inc, Ratios based on current share price 23

bluebird bio Inc, Annual Ratios 24

bluebird bio Inc (Cont...1), Annual Ratios 25

bluebird bio Inc, Interim Ratios 27

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30

bluebird bio Inc, Recent Deals Summary 31

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 46

Efficiency Ratios 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sangamo Therapeutics Inc, Novartis AG, Kite Pharma Inc, Juno Therapeutics Inc, Intellia Therapeutics Inc, GlycoMimetics Inc, Global Blood Therapeutics Inc, Bellicum Pharmaceuticals Inc, ApoPharma Inc, Adaptimmune LLC, Acceleron Pharma Inc

bluebird bio Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com